Cargando…

Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab

Detalles Bibliográficos
Autores principales: Mamesaya, Nobuaki, Kenmotsu, Hirotsugu, Takahashi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694521/
https://www.ncbi.nlm.nih.gov/pubmed/28466377
http://dx.doi.org/10.1007/s10637-017-0471-y
_version_ 1783280150397321216
author Mamesaya, Nobuaki
Kenmotsu, Hirotsugu
Takahashi, Toshiaki
author_facet Mamesaya, Nobuaki
Kenmotsu, Hirotsugu
Takahashi, Toshiaki
author_sort Mamesaya, Nobuaki
collection PubMed
description
format Online
Article
Text
id pubmed-5694521
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-56945212017-11-30 Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab Mamesaya, Nobuaki Kenmotsu, Hirotsugu Takahashi, Toshiaki Invest New Drugs Short Report Springer US 2017-05-02 2017 /pmc/articles/PMC5694521/ /pubmed/28466377 http://dx.doi.org/10.1007/s10637-017-0471-y Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Short Report
Mamesaya, Nobuaki
Kenmotsu, Hirotsugu
Takahashi, Toshiaki
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
title Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
title_full Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
title_fullStr Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
title_full_unstemmed Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
title_short Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
title_sort successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694521/
https://www.ncbi.nlm.nih.gov/pubmed/28466377
http://dx.doi.org/10.1007/s10637-017-0471-y
work_keys_str_mv AT mamesayanobuaki successfulosimertinibrechallengeinapatientwithadvancednonsmallcelllungcancerfollowingosimertinibinducedinterstitiallungdiseaseaftertreatmentwithnivolumab
AT kenmotsuhirotsugu successfulosimertinibrechallengeinapatientwithadvancednonsmallcelllungcancerfollowingosimertinibinducedinterstitiallungdiseaseaftertreatmentwithnivolumab
AT takahashitoshiaki successfulosimertinibrechallengeinapatientwithadvancednonsmallcelllungcancerfollowingosimertinibinducedinterstitiallungdiseaseaftertreatmentwithnivolumab